Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries
Clinical trial NCT02339818 · COMPLETED
Trial details
- NCT number
- NCT02339818
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-02-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.